首页 | 本学科首页   官方微博 | 高级检索  
检索        

不同途径注射树突状细胞在肿瘤治疗中的研究进展
引用本文:占景华,;石鹤坤,;陈素明,;胡永狮.不同途径注射树突状细胞在肿瘤治疗中的研究进展[J].医学综述,2014(24):4477-4479.
作者姓名:占景华  ;石鹤坤  ;陈素明  ;胡永狮
作者单位:[1]解放军第一七五医院,中心实验室,福建漳州363000; [2]解放军第一七五医院,药学科,福建漳州363000
摘    要:树突状细胞(DC)是机体功能最强的专职抗原呈递细胞,不同的注射途径可引发机体的不同部位产生不同程度的免疫应答,决定了T细胞在淋巴组织中的分布,从而产生不同的抗肿瘤效应。该文通过查阅DC疫苗皮下注射、静脉注射及瘤内注射等途径治疗肿瘤的相关文献,阐述注射后机体产生不同程度的免疫应答、对肿瘤发展的影响及DC疫苗在机体不同部位皮内注射产生免疫功能和疼痛程度的影响。

关 键 词:树突状细胞  注射途径  免疫治疗

Research Advances in Dendritic Cells Injection Treatment of Tumor at Different Routes
Institution:ZHAN Jing-Hua,SHI He-kun, CHEN Su-ming,HU Yong-shi( 1. Department of Cell Biotherapy, 2. Department of Pharmacy ,PLA 175^th Hospital ,Zhangzhou 363000, China)
Abstract:Dendritic cell (DC) is antigen-presenting cell with the strongest function in vivo. Different injection routes can trigger different levels of immune response on different parts of the body, which decides the distribution of T cell in lymphoid tissue and gives rise to different antineoplastic effects. By consulting relevant documents on subcutaneous injection,intravenous injection,intratumor injection, etc. , here is to elaborate the different levels of immune response of the body after injection, impact on cancer development and impact on immunity generation and pain degree by DC vaccine intradermal injection on different parts of the body.
Keywords:Dendritic ceils  Injection route  Immunotherapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号